Murali Prahalad's Email & Phone Number

💼 Past Experience

Murali Prahalad's work experience at Life Technologies spanned 5 years 9 months with a focus on the cell analysis business unit. He wasVP Corporate Strategy at Life Technologies from August 2013 to April 2019 where his role included managing Life Technologies portfolio of reagents for basic cell biology research and flow cytometry. He held various other leadership positions at Iridium, Inc (President & CEO from 2007 to 2009) and Maravai Life Sciences (Board Member from 2009 to 2013). He also has experience as a President & CEO at Epic Sciences where he served from August 2013 to April 2019.

🎓 Education

Murali started his career as an Assistant Professor at Massachusetts Institute of Technology (MIT) in 1998. He then went on to become the Professor of Genome Biology at Brown University in 2007. At Brown University, Murali's research focuses on chromosome assembly, chromatin remodeling, and gene expression.Murali Prahalad's current research focus focuses on the sequencing, transcriptomics, and epigenomics of aging cells. In particular, he is working on thevindication of deleted endogenous genes as well as the characterization of the epigenetic plasticity of cells in response to stress.Murali Prahalad has also been involved in Theskaku Trust Institute's (TIST) ' fund-raiser for South Asia' program. In this program, Murali helps to support the development of research fellows in South Asia who are working on important scientific projects.Murali Prahalad is a well-educated scientist and has a strong academic background. In addition, he is very well- readiness to carry out his research in a highly dedicated and professional manner.

💡 Technical & Interpersonal Skills

Murali Prahalad is a Member Board of Directors at Maravai LifeSciences. He is currently a Member Board of Directors at Epic Sciences. VP Corporate Strategy at Life Technologies from January 2012 to August 2013 (1 year 8 months). General Manager, Cell Analysis Business Unit at Life Technologies from December 2008 to December 2011 (3 years 1 month). Manages Life Technologies portfolio of reagents for basic cell biology research and flow cytometry. Products include dyes, sensors, substrates, quantum dots and conjugates from Molecular Probes as well as its antibody portfolio from Zymed, Caltag and Biosource. In addition Life Technologies new line of flow cytometry instrumentation is part of this portfolio. VP, Molecular Biology Essentials at Life Technologies from July 2007 to January 2009 (1 year 7 months). President & CEO at Iridia, Inc in Carlsbad, CA. Board Member at Maravai LifeSciences. President & CEO at Epic Sciences from August 2013 to April 2019 (5 years 9 months) in 10975 N. Torrey Pines Rd., La Jolla, CA 92037.